Records containing: Non-Alcoholic Fatty Liver Disease
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-02-05A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of MN-001 in Patients Diagnosed With Non-alcoholic Fatty Liver Disease, Type 2 Diabetes Mellitus, and Hypertriglyceridemia
-
CLINICAL_TRIALS study record update · 2026-01-27Pilot Study of On-Cart Liver Fat Quantification (LFQ) Feature to Assess Correlation With Magnetic Resonance Imaging Proton Density Fat Fraction (MRI-PDFF) Results in a Pediatric Population
-
CLINICAL_TRIALS study record update · 2026-01-23Pilot Study of On-Cart Liver Fat Quantification (LFQ) Feature to Assess Correlation With Magnetic Resonance Imaging Proton Density Fat Fraction (MRI-PDFF) Results
-
CLINICAL_TRIALS study record update · 2026-01-21Mechanisms of SGLT2 Inhibition in Pediatric Steatotic Liver Disease
-
CLINICAL_TRIALS study record update · 2026-01-20SGLT2 Inhibitors as a Novel Treatment for Pediatric Non-Alcoholic Fatty Liver Disease
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-01-16The Olmsted NAFLD Epidemiology Study (TONES)
-
CLINICAL_TRIALS study record update · 2026-01-12Role of Hyperinsulinemia in Non-Alcoholic Fatty Liver Disease (NAFLD) Pathogenesis: Pancreatic Clamp Pilot & Feasibility Study
-
CLINICAL_TRIALS study record update · 2026-01-09Quantitation of Hepatic Mitochondrial Fluxes in Humans With Nonalcoholic Fatty Liver Disease (NAFLD)
-
CLINICAL_TRIALS study record update · 2026-01-07Role of Hyperinsulinemia in Non-Alcoholic Fatty Liver Disease (NAFLD) Pathogenesis: Diazoxide Pilot & Feasibility Study
-
CLINICAL_TRIALS study record update · 2025-12-19Impact of Lifestyle Interventions on Cognitive Decline in NAFLD: A Randomized Controlled Trial of Liver Fibrosis, Hormonal Imbalance, and Inflammatory Markers
-
CLINICAL_TRIALS study record update · 2025-12-19Screening for NAFLD-related Advanced Fibrosis in High Risk popuLation: Optimization of the Diabetology Pathway Referral Using Combinations of Non-invAsive Biological and elastogRaphy paramEters
-
CLINICAL_TRIALS study record update · 2025-12-18Pilot Study of Time-Restricted, Intermittent Fasting for Non-Alcoholic Fatty Liver Disease in Non-Obese Adults
-
CLINICAL_TRIALS study record update · 2025-12-10Improving Diagnostic Safety Through STeatosis Identification, Risk Stratification, and Referral in the ED (STIRRED)
-
CLINICAL_TRIALS study record update · 2025-12-08The Association of Sodium-Glucose Cotransporter 2 Inhibitors Therapy With Elastographic and Molecular Markers of Liver Injury in Patients With Type 2 Diabetes Mellitus
-
CLINICAL_TRIALS study record update · 2025-12-02Effect of Endoscopic Sleeve Gastroplasty on Patients With Obesity and Concomitant Metabolic Dysfunction-Associated Steatohepatitis (MASH): A Multicenter, Open-label, Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2025-12-01The Economic Burden of Non-Alcoholic Fatty Liver Disease Patients in Flanders, Belgium
-
CLINICAL_TRIALS study record update · 2025-12-01Screening for Non-Alcoholic Fatty Liver Disease (NAFLD) in a General Practitioner Population, in Flanders, Belgium.
-
CLINICAL_TRIALS study record update · 2025-12-01Repeatability and Reproducibility of Multiparametric MRI (LiverMultiScan)
-
CLINICAL_TRIALS study record update · 2025-11-20Growth Hormone Releasing Hormone Analog to Improve Nonalcoholic Fatty Liver Disease and Associated Cardiovascular Risk
-
CLINICAL_TRIALS study record update · 2025-10-14Nonalcoholic Fatty Liver Disease (NAFLD), Insulin Resistance and Dyslipidemia in Adolescents and Young Adults With Polycystic Ovary Syndrome (PCOS)
-
CLINICAL_TRIALS study record update · 2025-10-02Non-Alcoholic Fatty Liver Disease, the Hepatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)
-
CLINICAL_TRIALS study record update · 2025-09-30Motivational Interviewing for Weight Loss in the Management of Non Alcoholic Fatty Liver Disease - A Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2025-09-25Alternate Day Fasting Combined With Exercise for the Treatment of Non-alcoholic Fatty Liver Disease (NAFLD)
-
CLINICAL_TRIALS study record update · 2025-09-16Ultrasound Liver Fat Quantification on Pediatric Patients
-
CLINICAL_TRIALS study record update · 2025-08-26The Effect of GLP-1 Analogues on Liver Steatosis and Fibrosis in Diabetic and Obese Patients in a Clinical Setting